Abstract
Background
The objective of the current study was to identify variables that were predictive of cancer-specific survival in patients with nonmetastatic transitional cell carcinoma of the upper urinary tract (UUT-TCC).Methods
Clinical and pathologic data from 269 patients who underwent nephroureterectomy for UUT-TCC from 1989 to 2005 in 3 urologic European centers were collected retrospectively. Log-rank tests and Cox proportional-hazards regression models were used for univariate and multivariate analyses.Results
Two hundred fifty patients underwent nephroureterectomy, and 19 patients underwent concomitant cystectomy for synchronous muscle-invasive bladder cancer. The median follow-up of the whole cohort was 34 months, and the median follow-up of the patients who remained alive and disease-free was 52 months. At follow-up, 57 cancer-related deaths (21.2%) were censored, and 169 patients (62.8%) were alive and disease-free. On univariate analysis, a history of previous bladder cancer, pathologic stage of the primary tumor and lymph nodes, tumor grade, the presence of lymphovascular invasion, tumor site, synchronous muscle-invasive bladder TCC, and tumor multifocality were associated with cancer-specific survival probabilities. On multivariate analysis, pathologic stage of the primary tumor and lymph nodes, tumor multifocality within the UUT, synchronous muscle-invasive bladder TCC, and a history of bladder TCC before the diagnosis of UUT-TCC were independent predictors of cancer-specific survival probabilities.Conclusions
In a multi-institutional dataset of patients who had undergone nephroureterectomy for UUT-TCC, the current results indicated that pathologic stage of the primary tumor and lymph nodes, a history of prior bladder TCC, the presence of synchronous muscle-invasive bladder cancer, and tumor multifocality within the UUT were independent predictors of cancer-specific survival probabilities.Full text links
Read article at publisher's site: https://doi.org/10.1002/cncr.22970
Read article for free, from open access legal sources, via Unpaywall: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cncr.22970
References
Articles referenced by this article (25)
Upper tract urothelial neoplasms: incidence and survival during the last 2 decades.
J Urol, (5):1523-1525 2000
MED: 11025695
Prognostic factors, recurrence, and survival in transitional cell carcinoma of the upper urinary tract: a 30-year experience in 252 patients.
Urology, (4):594-601 1998
MED: 9763077
Renal pelvic cancer: a review of 611 patients treated in Illinois 1975-1985. Cancer Incidence and End Results Committee.
Urology, (5):393-399 1992
MED: 1441034
Prognostic factors in urothelial renal pelvis and ureter tumours: a multicentre Rare Cancer Network study.
Eur J Cancer, (5):738-743 1999
MED: 10505034
Upper-tract tumors after an initial diagnosis of bladder cancer: argument for long-term surveillance.
J Clin Oncol, (1):94-100 2001
MED: 11134200
Bladder cancer as a prognostic factor for upper tract transitional cell carcinoma.
J Urol, (6 Pt 1):2177-2181 2004
MED: 15538226
Prognostic value of lymphovascular invasion in transitional cell carcinoma of upper urinary tract.
Urology, (4):692-696 2005
MED: 15833510
Upper urinary tract cancer: location is correlated with prognosis.
Eur Urol, (3):438-444 2005
MED: 16115524
Show 10 more references (10 of 25)
Citations & impact
Impact metrics
Citations of article over time
Article citations
Advanced Age May Not Be an Absolute Contraindication for Radical Nephroureterectomy in Patients with Upper Tract Urothelial Carcinoma: A Single-Center Case Series and a Systematic Review with Meta-Analyses.
J Clin Med, 12(23):7273, 24 Nov 2023
Cited by: 1 article | PMID: 38068325 | PMCID: PMC10707095
Review Free full text in Europe PMC
The prognostic impact of lymphovascular invasion for upper urinary tract urothelial carcinoma: A propensity score-weighted analysis.
Medicine (Baltimore), 102(15):e33485, 01 Apr 2023
Cited by: 1 article | PMID: 37058048 | PMCID: PMC10101277
Clinical Characteristics and Current Status of Treatment for Recurrent Bladder Cancer after Surgeries on Upper Tract Urothelial Carcinoma.
Diagnostics (Basel), 13(5):1004, 06 Mar 2023
Cited by: 3 articles | PMID: 36900148 | PMCID: PMC10000489
Review Free full text in Europe PMC
Prognostic Value of Bladder Involvement in the Outcome of Upper Tract Urothelial Carcinoma.
Diagnostics (Basel), 13(1):153, 02 Jan 2023
Cited by: 3 articles | PMID: 36611446 | PMCID: PMC9818601
Subclassification of pT3 upper tract urothelial carcinoma: a multicenter retrospective study.
World J Urol, 41(3):767-776, 04 Feb 2023
Cited by: 3 articles | PMID: 36739339
Go to all (121) article citations
Similar Articles
To arrive at the top five similar articles we use a word-weighted algorithm to compare words from the Title and Abstract of each citation.
Independent predictors of contralateral metachronous upper urinary tract transitional cell carcinoma after nephroureterectomy: multi-institutional dataset from three European centers.
Int J Urol, 16(2):187-191, 27 Nov 2008
Cited by: 35 articles | PMID: 19054165
Pathologic features of bladder tumors after nephroureterectomy or segmental ureterectomy for upper urinary tract transitional cell carcinoma.
Urology, 69(2):251-254, 01 Feb 2007
Cited by: 26 articles | PMID: 17320658
Independent predictors of metachronous bladder transitional cell carcinoma (TCC) after nephroureterectomy for TCC of the upper urinary tract.
BJU Int, 101(11):1368-1374, 30 Jan 2008
Cited by: 61 articles | PMID: 18241252
Initial tumor stage and grade as a predictive factor for recurrence in patients with stage T1 grade 3 bladder cancer.
J Urol, 171(1):149-152, 01 Jan 2004
Cited by: 28 articles | PMID: 14665864
Review